<?xml version="1.0"?>
<oembed><version>1.0</version><provider_name>Carduso Capital</provider_name><provider_url>https://cardusocapital.com/nl/</provider_url><author_name>webmaster</author_name><author_url>https://cardusocapital.com/nl/author/webmaster/</author_url><title>Carduso Capital investeert in &#x201C;AGILeBiotics&#x201D; - Carduso Capital</title><type>rich</type><width>600</width><height>338</height><html>&lt;blockquote class="wp-embedded-content" data-secret="20eKyRCncR"&gt;&lt;a href="https://cardusocapital.com/nl/carduso-capital-investeert-agilebiotics/"&gt;Carduso Capital investeert in &#x201C;AGILeBiotics&#x201D;&lt;/a&gt;&lt;/blockquote&gt;&lt;iframe sandbox="allow-scripts" security="restricted" src="https://cardusocapital.com/nl/carduso-capital-investeert-agilebiotics/embed/#?secret=20eKyRCncR" width="600" height="338" title="&#x201C;Carduso Capital investeert in &#x201C;AGILeBiotics&#x201D;&#x201D; &#x2014; Carduso Capital" data-secret="20eKyRCncR" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"&gt;&lt;/iframe&gt;&lt;script type="text/javascript"&gt;
/*! This file is auto-generated */
!function(c,d){"use strict";var e=!1,o=!1;if(d.querySelector)if(c.addEventListener)e=!0;if(c.wp=c.wp||{},c.wp.receiveEmbedMessage);else if(c.wp.receiveEmbedMessage=function(e){var t=e.data;if(!t);else if(!(t.secret||t.message||t.value));else if(/[^a-zA-Z0-9]/.test(t.secret));else{for(var r,s,a,i=d.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),n=d.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),o=new RegExp("^https?:$","i"),l=0;l&lt;n.length;l++)n[l].style.display="none";for(l=0;l&lt;i.length;l++)if(r=i[l],e.source!==r.contentWindow);else{if(r.removeAttribute("style"),"height"===t.message){if(1e3&lt;(s=parseInt(t.value,10)))s=1e3;else if(~~s&lt;200)s=200;r.height=s}if("link"===t.message)if(s=d.createElement("a"),a=d.createElement("a"),s.href=r.getAttribute("src"),a.href=t.value,!o.test(a.protocol));else if(a.host===s.host)if(d.activeElement===r)c.top.location.href=t.value}}},e)c.addEventListener("message",c.wp.receiveEmbedMessage,!1),d.addEventListener("DOMContentLoaded",t,!1),c.addEventListener("load",t,!1);function t(){if(o);else{o=!0;for(var e,t,r,s=-1!==navigator.appVersion.indexOf("MSIE 10"),a=!!navigator.userAgent.match(/Trident.*rv:11\./),i=d.querySelectorAll("iframe.wp-embedded-content"),n=0;n&lt;i.length;n++){if(!(r=(t=i[n]).getAttribute("data-secret")))r=Math.random().toString(36).substr(2,10),t.src+="#?secret="+r,t.setAttribute("data-secret",r);if(s||a)(e=t.cloneNode(!0)).removeAttribute("security"),t.parentNode.replaceChild(e,t);t.contentWindow.postMessage({message:"ready",secret:r},"*")}}}}(window,document);
&lt;/script&gt;
</html><description>Doorbraak in de ontwikkeling van antibiotica tegen restistente bacterien Carduso Capital investeert in de Groningse onderneming AGILeBiotics B.V. die met haar platform technologie nieuwe antibiotica ontwikkeld voor de zeer snel groeiende markt van ziekenhuis behandelde multi drug resistente bacteri&#xEB;n. De basis van de onderneming vormt een wereldwijd gepatenteerd platform om verschillende antibiotica te synthetiseren, die [&hellip;]</description><thumbnail_url>https://cardusocapital.com/wp-content/uploads/2018/07/logo-agilebiotics-300x200.jpg</thumbnail_url></oembed>
